Drugs
Vaccinex Announces $3 Million Award from the Alzheim...
Vaccinex, Inc., a clinical-stage biotechnology company pioneering novel antibody therapies in neurodegenerative diseases and cancer, today announced that it has been granted an award, in the form of an investm...
December 10, 2019
1:19 pm By Meeta Ramnani
FDA Sends Warning to Companies for Offering Unapprov...
The U.S. Food and Drug Administration has warned Liveyon Labs Inc. (Liveyon Labs) and Liveyon LLC, of Yorba Linda, California, and their presidents and chief executive officers, Roya Panah and John W. Kosolch...
December 9, 2019
8:38 am By Neha Mule
Japan’s Astellas to Buy Audentes for $3 Billion in...
Japan’s Astellas Pharma Inc. has agreed to buy Audentes Therapeutics Inc. for about $3 billion in cash as it seeks to make genetic medicines a key area of growth.
Gene therapies are one of the hotte...
December 3, 2019
6:21 am By Neha Mule
Celltrion Healthcare Receives EU Marketing Authorisa...
Celltrion Healthcare announced that the European Commission has approved Remsima SC (CT-P13 SC, biosimilar infliximab) for patients with RA. Remsima SC is the world’s first subcutaneous formulation of inf...
November 26, 2019
10:14 am By Neha Mule
Novartis to Acquire the Medicines Company for USD 9....
The Medicines Company (NASDAQ: MDCO) announced today that it has entered into definitive agreement in which Novartis AG will acquire The Medicines Company for $85 per share in an all-cash transaction, implying...
November 25, 2019
1:11 pm By Neha Mule
SK Life Science, Inc. Receives US FDA Approval for C...
Arvelle Therapeutics GmbH announced that SK Life Science has received approval from the U.S. Food and Drug Administration (FDA) for cenobamate tablets, as a treatment for partial-onset seizures in adults (now ...
November 25, 2019
10:24 am By Neha Mule
CStone Announces First Patient Dosed in the Phase I ...
CStone Pharmaceuticals announced that the first patient has been dosed in the Phase I bridging registrational study of ivosidenib (TIBSOVO) in China.
This stand-alone trial is designed to validate the...
November 20, 2019
11:45 am By Neha Mule